STOCK TITAN

Innovative Eyewear (LUCY) insider granted 41,800 shares, sells 13,627

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski. He received grants of 20,900 shares of common stock on April 2, 2026 and August 19, 2026, each at no cost, and sold 6,692 shares on April 2 at $1.0581 per share and 6,935 shares on August 19 at a weighted-average price of $0.6911 per share in open-market or private transactions. Post-transaction holdings were not provided.

Positive

  • None.

Negative

  • None.
Insider Dabrowski Konrad
Role Chief AI & Growth Officer
Sold 13,627 shs ($12K)
Type Security Shares Price Value
Grant/Award Common Stock 20,900 $0.00 $0.00
Sale Common Stock F1 6,935 $0.6911 $5K
Grant/Award Common Stock 20,900 $0.00 $0.00
Sale Common Stock 6,692 $1.0581 $7K
Holdings After Transaction: Common Stock — 40,977 shares (Direct)
Footnotes (1)
  1. F1. The price reported in Column 4 is an average price of $0.6911. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Shares granted on April 2, 2026 20,900 shares of Common Stock Grant, award, or other acquisition at $0.0000 per share
Shares sold on April 2, 2026 6,692 shares of Common Stock Sale in open market or private transaction at $1.0581 per share
Shares granted on August 19, 2026 20,900 shares of Common Stock Grant, award, or other acquisition at $0.0000 per share
Shares sold on August 19, 2026 6,935 shares of Common Stock Sale at weighted-average price of $0.6911 per share
Total shares sold in reported period 13,627 shares of Common Stock Aggregate of April 2 and August 19, 2026 sales
Grant, award, or other acquisition regulatory
"transaction code "A" described as Grant, award, or other acquisition"
Sale in open market or private transaction financial
"transaction code "S" described as Sale in open market or private transaction"
weighted-average price financial
"The price reported in Column 4 is an average price of $0.6911"
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

FAQ

What insider transactions did LUCY report for Konrad Dabrowski on April 2, 2026?

On April 2, 2026, Konrad Dabrowski was granted 20,900 shares of Innovative Eyewear common stock at $0.00 per share and sold 6,692 shares in an open-market or private transaction at $1.0581 per share.

What insider transactions did LUCY report for Konrad Dabrowski on August 19, 2026?

On August 19, 2026, Konrad Dabrowski received a grant of 20,900 shares of common stock at $0.00 per share and sold 6,935 shares at a weighted-average price of $0.6911 per share in open-market or private transactions.

How many LUCY shares did Konrad Dabrowski sell according to this Form 4?

Across the reported transactions, Konrad Dabrowski sold a total of 13,627 shares of Innovative Eyewear common stock: 6,692 shares on April 2, 2026 at $1.0581 per share and 6,935 shares on August 19, 2026 at a weighted-average price of $0.6911 per share.

Were Konrad Dabrowski’s LUCY trades made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not checked, and the footnotes do not reference a trading plan. The Form 4 therefore does not state that Konrad Dabrowski’s transactions were executed under a Rule 10b5-1 trading arrangement.

Does the Form 4 disclose Konrad Dabrowski’s LUCY share ownership after these transactions?

The Form 4 lists the shares transacted and the per-share prices, but the fields for total shares beneficially owned following each transaction are left blank, so post-transaction ownership amounts are not disclosed in this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dabrowski Konrad

(Last)(First)(Middle)
C/O INNOVATIVE EYEWEAR INC.
11900 BISCAYNE BLVD., SUITE 630

(Street)
MIAMI FLORIDA 33181

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief AI & Growth Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/02/2026A20,900A$0.0033,704D
Common Stock04/02/2026S6,692D$1.058127,012D
Common Stock08/19/2026A20,900A$0.0047,912D
Common Stock08/19/2026S6,935D$0.6911(1)40,977D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is an average price of $0.6911. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Konrad Dabrowski08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)